MAPT and early-onset autosomal dominant Alzheimer disease: For example measurements of P-tau in the blood can identify those with familial Alzheimer's disease, those with pre-clinical amyloid, those individuals with Down's syndrome who start to develop Alzheimer's disease, and distinguish between Alzheimer's and other neurodegenerative diseases such as frontotemporal dementia and Parkinsonian disorders [36–38].